Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Ocrelizumab
- Livnat Brill
- , Ariel Rechtman
- , Omri Zveik
- , Nitzan Haham
- , Esther Oiknine-Djian
- , Dana G. Wolf
- , Netta Levin
- , Catarina Raposo
- , Adi Vaknin-Dembinsky*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
148
Scopus
citations